Rare diseases
Investigational molecules
Locations
M. R. Stefanika 25a/3782, 075 01 Trebisov, Slovakia
Areteus s.r.o. in Trebisov, Slovakia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Overweight, Dyslipidaemia, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Severe Hypertriglyceridemia (SHTG), focusing on innovative treatments to manage this complex condition. The ongoing study of olezarsen aims to assess its safety and tolerability when administered subcutaneously, offering new hope for patients with elevated triglyceride levels.
Through this research, the center contributes significantly to the understanding and management of lipid disorders, potentially transforming therapeutic approaches for patients with severe lipid imbalances.
Specializing in Type 2 Diabetes Mellitus, the center is dedicated to advancing treatment options that improve glycemic control. The study of AZD5004 versus placebo over a 26-week period is designed to evaluate its efficacy, safety, and tolerability, providing critical insights into daily oral administration therapies.
This research underscores the center's commitment to developing effective diabetes management strategies, enhancing patient outcomes through cutting-edge clinical trials.
Clinical trials currently enrolling participants at this site.
Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
SlovakiaA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
SlovakiaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
SlovakiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
SlovakiaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
SlovakiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
SlovakiaStudy of ISIS 678354 for Patients with Severe High Triglycerides
SlovakiaStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
SlovakiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SlovakiaStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
SlovakiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
SlovakiaStudy on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes
SlovakiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
